Analyst consensus rating
OKYO Pharma Analyst Rating: Strong Buy
OKYO is rated Strong Buy by 3 analysts with a $8.33 target. As of 2026-08-31.
Direct answer
OKYO Pharma's consensus rating is Strong Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $8.33.
Forecast evidence checked August 31, 2026.
Get free OKYO Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.67
- Average price target
- $8.33
- High price target
- $13.00
- Low price target
- $5.00
- Low target gap
- +199.4%
- Target upside
- +399%
- High target gap
- +678.4%
- Target range width
- 479%
- Consensus rating
- Strong Buy
- Analysts
- 3
- Evidence date
- August 31, 2026
- Valid through
- September 7, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for OKYO Pharma?
OKYO Pharma has a verified Strong Buy consensus. The same dataset has an average price target of $8.33.
How far are OKYO Pharma's low and high targets from the recorded price?
The low target implies +199.4%, while the high target implies +678.4%.
How many analysts are included in OKYO Pharma's consensus?
The verified consensus includes 3 analysts.
How is OKYO Pharma's target upside or downside calculated?
The average target of $8.33 is divided by the recorded price of $1.67, then one is subtracted to produce +399%. This does not guarantee a future return.
When was OKYO Pharma's analyst forecast verified?
The data was verified on 2026-08-31. The dataset is valid through 2026-09-07.